(BUSINESS WIRE)– Gemalto (Euronext NL0000400653 GTO), the world leader in digital security, announces that Al Rajhi Bank, the largest financial institution in Saudi Arabia, has completed the main phase of the Dexxis Instant Issuancedeployment program for on-the-spot EMV card delivery. With more than 500 branches equipped nationwide and over 15,000 cards issued daily, Al Rajhi Bank embarked on the largest rollout of any smart banking card instant issuance solution. Gemalto’s unique offer encompasses highly secure EMV DDA1 payment cards, a complete, mission-critical issuance solution along with a full set of services: training, end-to-end project management, maintenance and support.

Al Rajhi Bank branches can now securely issue EMV cards to new and existing customers with just one click, from an Arabic-customized interface specially designed for ease-of-use. With card personalization made so swift and simple, Al Rajhi customers walk away with an activated, ready-to-use card in hand in just a few minutes. By deploying Gemalto’s solution, Al Rajhi Bank significantly improved on the logistical challenges associated with traditional courier-based delivery services and reduced its associated costs.

In order to ensure full service continuity, the solution can easily redirect card requests from one branch to another, and it also retains central issuance as a back-up system. The high level of reliability of the complete solution has already enabled Al Rajhi to issue half a million EMV chip cards on-the-spot to customers over the last six months.

“Gemalto was able to meet our needs for both the more sophisticated cards and the complete issuance services,” said Dr. Abdullah Al-Namlah, Retail General Manager, Al Rajhi Bank. “Al Rajhi has been delivering payment cards at the branch for years so when we determined to switch to EMV, we naturally selected the partner with the broadest experience in EMV instant issuance solutions globally.”

“Advanced banking solutions and services are key to our growth strategy”, added Philippe Cambriel, Executive Vice-President at Gemalto. “We are pleased with this successful deployment with Al Rahji Bank, which illustrates nicely the performance of our Instant Issuance solution, and demonstrates once again our expertise in EMV card systems and their successful deployment. It is rewarding for us to see that this nationwide program has visibly benefited the bank and projected a first-class image to its customers.”

1 Dynamic Data Authentication (DDA), offers a dynamic security feature which helps to reduce fraud by detecting counterfeit and duplicate cards

View Dexxis Instant Issuance video: http://www.gemalto.com/financial/solutions/issuance_video.html

About Gemalto

Gemalto (Euronext NL0000400653 GTO) is the world leader in Digital Security with 2010 annual revenues of €1.9 billion and over 10,000 employees operating out of 87 offices and 13 Research & Development centers in 45 countries.

Gemalto is at the heart of our evolving digital society. Billions of people worldwide increasingly want the freedom to communicate, travel, shop, bank, entertain, and work—anytime, anywhere, in ways that are convenient, enjoyable and secure. Gemalto delivers on the growing demands for personal mobile services, identity protection, payment security, authenticated online services, cloud computing access, modern transportation, e-healthcare and e-government services. Gemalto does this by providing secure software, a wide range of secure personal devices, and managed services to wireless operators, banks, enterprises and government agencies.

Gemalto is the world leader for electronic passports and identity cards, two-factor authentication devices for online protection, smart credit/debit and contactless payment cards, as well as subscriber identification modules (SIM) and universal integrated circuit cards (UICC) in mobile phones. Also, in the emerging machine-to-machine applications Gemalto is a leading supplier of wireless modules and machine identification modules (MIM). To operate these solutions and remotely manage the software and confidential data contained in the secure devices Gemalto also provides server platforms, consulting, training, and managed services to help its customers achieve their goals.

As the use of Gemalto’s software and secure devices increases with the number of people interacting in the digital and wireless world, the Company is poised to thrive over the coming years. For more information visit www.gemalto.com, www.justaskgemalto.com, blog.gemalto.com, or follow @gemaltoon Twitter.

Contacts

Gemalto

Media

Europe, Middle East & Africa

Peggy Edoire, +33 4 42 36 45 40

peggy.edoire@gemalto.com

Latin America

Ernesto Haikewitsch, +55 11 51 05 92 20

ernesto.haikewitsch@gemalto.com

North America

Jessi Marshall, +1-512-257-3902

jessi.marshall@gemalto.com

Asia Pacific

Yvonne Lim, +65 6317 3730

yvonne.lim@gemalto.com

FOLSOM, Calif. – Tuesday, February 7th 2012 [ME NewsWire]

(BUSINESS WIRE)– Meridian Systems, a Trimble Company (NASDAQ:TRMB) and the Plan-Build-Operate technology solutions leader for project-based organizations, announced today a new Value Added Reseller (VAR) agreement with Zone Technology. Concentrating on building and infrastructure program owners and managers in Egypt, Zone will provide comprehensive software sales and professional services for Meridian’s Proliance® solution to enhance the productivity, cost control and scheduling of local projects.

“Zone is well positioned with program management providers and consultants, multinational firms focused on the oil sector, developers in Egypt’s tourism and real estate sector, and with public sector clients,” said Geene Alhady, general manager, Meridian Systems. “This makes them a great addition to our international-based VAR network as they work with clients in Egypt to deliver a suite of engineering and survey solutions along with Meridian’s Proliance solution.”

“Egypt is in need of top notch software solutions to further enable our engineering community to manage their projects using best practices,” said Ahmed Kandil, MS, PE, PMP, Zone Technology. “We are particularly excited to introduce our current client base, which includes construction consultants and oil and gas customers in the area, to solutions that can effectively automate their business practices and save time and effort.”

Meridian’s global reseller network enhances customers’ investments in Meridian software solutions by providing in-depth industry experience and value-added implementation and training services. For more information, visit: http://www.meridiansystems.com/partners/findreseller.asp.

About Zone

ZONE Technologies is a multi-disciplined geospatial engineering company based in Cairo, Egypt. The company carries out operations throughout Africa and the Middle East for clients engaged in a wide diversity of industry sectors such as constructions, oil and gas, engineering, environmental monitoring, pipeline integrity, and property and geophysical studies. In addition to survey and engineering activities Zone is also provider and supplier of Global Positioning System (GPS) and Geographic Information Systems (GIS) products, services and training in its role as an Egyptian distributor of Trimble, a leading provider of advanced positioning solutions. Zone has a training facility, Zone Offshore, which provides comprehensive training services to enhance software solutions specifically for the oil and gas sector.

Meridian in the Middle East

Meridian Systems construction project management software solutions for infrastructure building owners, program management firms, and other AEC organizations are available through its parent company, Trimble, which has local dealers in the UAE.

About Meridian Systems

Meridian Systems, a Trimble Company (NASDAQ:TRMB), is the Plan-Build-Operate technology solutionsleader for project-based organizations. Building owners, construction and engineering firms, and public agencies use Meridian software to effectively manage capital building and facility renovation programs. In 2011, Meridian secured the top spot among off-the-shelf project management software used by the construction industry1. Meridian also is a pioneer in combining plan-build-operate features on an open technology platform to provide infrastructure lifecycle management solutions for capital building owners. Download free Meridian research and case studies by going to: http://my.meridiansystems.com/downloads/

12011 IT Playbook, Constructech Magazine

Contacts

Zone Contact

Ahmed H. Kandil, MS, PE, PMP, +2 010 1111323

akandila2010@yahoo.com

Meridian Contact

Tamara Kaestner, +1-916-294-2375

Sr. Marketing Manager

tkaestner@meridiansystems.com

SMILE FC System Corporation to accelerate deployment of fuel cells for next generation of eco cars

(BUSINESS WIRE)– Intelligent Energy, the global clean power systems company, and the Suzuki Motor Corporation, have today announced the creation of a joint venture company called SMILE FC System Corporation, to develop and manufacture air-cooled fuel cell systems for a range of industry sectors. The joint venture also includes a non-exclusive license agreement that gives Suzuki access to Intelligent Energy’s class-leading fuel cell technology for its next generation of environmentally friendly fuel cell vehicles.

Under the terms of the contract, both companies will take a 50 percent stake in the joint venture. SMILE FC System Corporation will be led by Mr. Osamu Honda, Executive Vice President and representative director for Suzuki Motor Corporation, who will become President of the JV. SMILE FC System Corporation will be headquartered in Hamamatsu City, Shizuoka, with operations initially based in Yokohama.

“Suzuki Motor Corporation has been developing fuel cell vehicles with Intelligent Energy since 2006, and this successful relationship has led to the formation of SMILE FC System Corporation,” explained Mr. Honda. “I believe that we can accelerate the commercialisation of fuel cell vehicles through this joint venture with Intelligent Energy.”

The agreement represents good value for both parties, enabling Suzuki cost-effective access to Intelligent Energy’s advanced fuel cell technology through partnering and licensing, thereby avoiding the higher costs associated with in-house development. Intelligent Energy will benefit from Suzuki’s production expertise and the emerging Japanese supply chain to jointly develop the next generation of automotive standard air-cooled fuel cell systems.

Phil Caldwell, newly appointed Board Member of SMILE FC System Corporation and Business Development Director at Intelligent Energy commented, “This joint venture is the latest exciting development in the successful relationship between Intelligent Energy and Suzuki, which has previously resulted in the Crosscage motorcycle and the Suzuki Burgman Fuel Cell Scooter. It is a big step towards the mass production of automotive fuel cell systems.” Equipped with Intelligent Energy’s air-cooled fuel cells, the Crosscage and Burgman motorcycles were exhibited at the 2007 and 2009 Tokyo Motor Show, and in 2011, the Fuel Cell Burgman Scooter became the world’s first fuel cell vehicle to achieve European Union Whole Vehicle Type Approval (WVTA).

“Combining Intelligent Energy’s market-leading fuel cell system technology with Suzuki’s mass production capabilities and supply chain excellence will accelerate the deployment, long term scalability and applicability of fuel cells for the next generation of eco cars, and other market segments,” explained Dr Henri Winand, Chief Executive, Intelligent Energy. “This non-exclusive agreement with the Suzuki Motor Corporation also provides further validation of our ‘design once, deploy many times’ proprietary technology and mutually beneficial partnering business model.”

About SMILE FC System Corporation

SMILE FC System Corporation Board:

• Osamu Honda, President and Representative Director (and Executive Vice President and Representative Director of Suzuki Motor Corporation);
• Masataka Yamakawa, Vice President and Representative Director (and Representative Director, IE Japan Ltd);
• Ichizo Aoyama, Board Member (and Managing Director and Executive Director at Suzuki Motor Corporation);
• Phil Caldwell, Board Member (and Business Development Director at Intelligent Energy Ltd);
• Kunio Nakamura, Auditor (and Auditor at Suzuki Motor Corporation).

The ratio of capital contribution to SMILE FC System Corporation is as follows: SMC (50%), IEHP (50%).

The SMILE FC System Corporation HQ is located at 300, Takatsuka-cho, Minami-ku, Hamamatsu-city, Shizuoka. The place of business for the corporation is 2-1, Sakuranamiki, tuduki-ku, Yokohama-city, Kanagawa.

About Intelligent Energy

Intelligent Energy is a leading clean power systems company with a globally scalable business, operating in the motive, stationary power and consumer electronics sectors. Our proprietary fuel cell technologies are designed for the mass market products of some of the world’s leading companies. Intelligent Energy continues to accelerate the commercial introduction of its technologies into very large and growing markets based on sound yet cost effective operations and partnerships. Intelligent Energy’s successes include building the world’s first purpose built fuel cell motorbike, and with partner Suzuki, the first ever fuel cell vehicle to achieve European Union type approval. The company also supplied the system to Boeing which powered the world’s first manned fuel cell aircraft.

In addition to visiting Intelligent Energy, more information is available via Twitter, Youtube, Flickrand LinkedIn.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50158527&lang=en

Contacts

AxiCom PR for Intelligent Energy

James Kennedy

james.kennedy@axicom.com

+44 020 8392 4091

FOLSOM, Calif. – Tuesday, February 7th 2012 [ME NewsWire]

(BUSINESS WIRE)– Meridian Systems, a Trimble Company (NASDAQ: TRMB) and the Plan-Build-Operate technology solutions leader for project-based organizations, announced today a new Value Added Reseller (VAR) agreement with Rayat Technology Est. (RTE). Concentrating on building and infrastructure program owners and program managers in the Saudi market, RTE will provide comprehensive software sales and provision of services for Meridian’s Proliance® solution.

“The addition of RTE to our partner network helps us to better serve clients in the construction and real estate, healthcare, utilities, oil & gas and public services sectors,” said Geene Alhady, general manager, Meridian Systems. “RTE’s skilled professionals have intimate knowledge of the Saudi market, and combined with a comprehensive sales and marketing team, they take a consultative approach to understanding customer needs.”

RTE is a Saudi establishment headquartered in Riyadh and operates in the information and communications technology (ITC) area through professionals with comprehensive experience and strong project management skills. As a leading provider of services and support for business critical solutions focusing on risk, service and resource management, RTE has built strong relationships with multi-national vendors and provides the market with best-of-breed products and solutions.

“Offering Proliance allows us to better satisfy the needs of the Saudi infrastructure market by allowing organizations to recognize fast ROI from the huge projects taking place in the region,” said Mr. Zouheir Diab, Executive Director, RTE. “Many of our customers, with whom we have a good history of IT consultation and services, requested a solution to streamline their operations and empower their project management practice. With Proliance, we are confident we can meet our customers needs.”

Meridian’s global partner network enhances customers’ investments in Meridian software solutions by providing in-depth industry experience and value-added implementation and training services. For more information, visit: http://www.meridiansystems.com/partners/findreseller.asp.

About Rayat Technology Est.

RTE is a Saudi establishment headquartered in Riyadh. Since 2004, RTE has been operating in the ICT area through professionals with experience and strong project management skills. RTE provides services and support for business critical solutions focusing on risk, service and resource management. Over the years, RTE has succeeded in building strong and beneficial relationships with multinational vendors and provides the market with best-of-breed products and solutions.

Meridian in the Middle East

Meridian Systems construction project management software solutions for infrastructure building owners, program management firms, and other AEC organizations are available through its parent company, Trimble, which has local dealers in the UAE.

About Meridian Systems

Meridian Systems, a Trimble Company (NASDAQ: TRMB), is the Plan-Build-Operate technology solutionsleader for project-based organizations. Building owners, construction and engineering firms, and public agencies use Meridian software to effectively manage capital building and facility renovation programs. In 2011, Meridian secured the top spot among off-the-shelf project management software used by the construction industry1. Meridian also is a pioneer in combining plan-build-operate features on an open technology platform to provide infrastructure lifecycle management solutions for capital building owners. Download free Meridian research and case studies by going to: http://my.meridiansystems.com/downloads/.

12011 IT Playbook, Constructech Magazine

Contacts

Meridian Systems

Tamara Kaestner, +1-916-294 2375

Sr. Marketing Manager

tkaestner@meridiansystems.com

(BUSINESS WIRE)– Inventory Locator Service,® LLC (ILS), home of the world’s most active aviation marketplace, ILSmart, recently selected Gael Ltd to represent and promote their Supply Chain Solutions across the Middle East region.

The partnership gives ILS an expanded reach in the rapidly developing market and provides Middle East organizations a local expert to assist with aviation, defense and marine supply chain management, safety and compliance solutions as well as consultancy and management services.

Don Wilson, vice president at ILS, said the new partnership is the latest step in an ongoing effort to build upon successful client relationships in the Gulf region.

“For more than 25 years, the Gulf has been an area of growth for ILS. Our new relationship with Gael Ltd will allow more continued direct contact and timely support for our clients in the region, including Etihad, Abu Dhabi Aircraft Technologies, Qatar Airways and Kuwait Airways.”

CEO of Gael Ltd Ashley Marron stated, “We are delighted to have been selected by ILS to represent them in the GCC region. We are excited about representing ILS because their product offerings are complimentary to ours and of significant interest within the marketplace in which we currently operate.”

Gael has an established operation in Dubai serving the Aviation marketplace in the region and in support of a wide range of customers – utilizing their Q-Pulse application to manage Aviation Safety and Quality Management (SMS & QMS).

About Gael: (www.gaelquality.com)

Since 1992, Gael has developed solutions to encourage organisations to focus on what’s important. The products and services provided by Gael have evolved enormously over the years, with each iteration designed to encourage organisations to do the ‘right things, right,’ allowing for the demonstration of compliance to auditors, customers, regulators and third party organisations as required.

About Inventory Locator Service,® LLC, a Boeing Subsidiary:(www.ILSmart.com)

Since 1979, ILS has provided information via its global electronic marketplace to enable customers in the aerospace, defense and marine industries to buy and sell parts, equipment and services. There are more than 5 billion parts listed, 60,000 customer accesses and 22,000 subscribers everyday on ILSmart, the most active business-to-business electronic marketplace serving these industries. ILS also provides Supply Chain Management Software solutions and powerful aftermarket trending tools.

Contacts

Inventory Locator Service, LLC

Joe Kaegi, 1-901-794-5000

Marketing Communication Specialist

jkaegi@ILSmart.com

www.ILSmart.com

Jeddah, Saudi Arabia – Monday, February 6th 2012 [ME NewsWire]

Saudi Arabia’s efforts to usher in the next stage of industrial development is set to receive a major boost as the 2nd edition of Machinex Arabia, the region’s premier industrial exhibition, kicks off in Jeddah later this month.

The exhibition, organized by Al Harithy Company for Exhibitions under the auspices of the Saudi Industrial Property Authority (MODON), takes place from February 19 to 22 at the Jeddah Centre for Forums and Events.

“As the most important regional event of its kind, Machinex Arabia 2012 aims to support the advancement of Saudi Arabia’s industrial sector and reduce the Kingdom’s reliance on imports by creating national industrial alternatives,” said Walid Saad Wakid, Vice President of Al Harithy Company for Exhibitions.

He added, “In light of the rapid expansion of the various industry sectors in Saudi Arabia, and due to the surge in construction and manufacturing activity, demand for machineries and equipment has been increasing steadily, pushing local companies and contractors to look for innovative products and solutions that would give them a competitive advantage.”

Wakid noted that the massive development projects in Saudi Arabia constantly require the best and most reliable resources, particularly industrial machineries and equipment. According to estimates, investment in infrastructure projects in the Kingdom topped USD 40 billion in 2011. This amount is expected to increase sharply over the next decade, and the total amount to be invested in Saudi Arabia in infrastructure in 2020 is estimated at a staggering USD 500 billion.

For Saudi Industrial Property Authority, support for Machinex Arabia 2012 continues their commitment to the industrial development of the Kingdom. The Authority has till date established 26 industrial cities in various parts of Saudi Arabia, 12 of which were built in the last three years.

MODON confirms that the number of industrial facilities in Saudi Arabia has doubled in the past few years with a total invested amount of USD 70 billion, leading to the recruitment of more than half a million people. Together, these facilities are expected to post revenues of more than USD 140 billion by 2015.

The development of industrial cities in Saudi Arabia is moving along at a rapid pace. In addition to the two Royal Commission industrial cities in Jubail and Yanbu, there are five other industrial cities currently under construction including the King Abdullah Economic City.

Noting that Machinex Arabia 2012 offered the perfect opportunity to take the infrastructure growth story forward, Wakid said, “The exhibition provides a solid platform for local industrialists and dealers to meet representatives of the world’s leading manufacturers; it affords them a unique opportunity to build new relationships and acquire new technologies that will help accelerate the development of the industrial sector in Saudi Arabia.”

- ends –

Contacts

Jumanah Y. Dukhan

Media Executive

Al Harithy Company for Exhibitions Ltd.

Tel: +966 2 654 6384 Ext: 169

Email: jumanah@acexpos.com

www.acexpos.com

Faces, the leading beauty destination for all of your fragrance, skincare and makeup desires presents you with an array of fragrances this Valentine’s Day!

Valentine’s Day is a day of sharing with loved ones, a day of pampering and telling those that are close to you how much they mean to you.

What better than the gift of Beauty to express your love and care?! At Faces, we have the newest romantic and feminine fragrances to offer to your loved ones and show them how special they are…and why not pick up a little something for yourself as well?

Play Sport by Givenchy

An emblematic sport fragrance. Boosted by the spicy freshness of citrus, mint and ginger, Play Sport’s heart notes of Amyris wood recall the sensuality and manliness of the PLAY franchise.

Hot water by Davidoff

Herein lays an erotic masculine virtue and a sensual warmth. The vibrant Red Basil and Absinthe top-note thrillingly grounded by the genuine class of Wormwood. An amatory heart-note of burning Pimento. An ultra-masculine dry-down of Benzoin Siam. Hot Water is fresh, spicy and jubilant.

Romantina by Juliette Has a Gun

Romantina is a musky composition in which we have delicately laid a bouquet of white flowers. An ode to Insouciance…Where Orange Blossom impulsively marries Jasmine; the Rose passionately blends with Iris and Osmanthus.

CH by Carolina Herrera

Fresh and floral! This is how Carolina likes to define her creation!

Nina L’Elixir by Nina Ricci

Nina L’Elixirevokes the rare and luxurious essence of a love potion, concentrated in an Eau de Parfum. An intense reinterpretation of Nina Eau de Toilette.

Lacoste Joy of Pink

The LACOSTE Pink woman exudes an aura of feel good, youthful optimism, and Joy Of Pink is the ideal fragrance to awaken the happiness and confidence she feels in social situations with her closest companions.

Chopard Happy Spirit Elixir D’Amour

Fullness and femininity are the signatures of the Happy Spirit Elixir D’Amour fragrance – a lush floral composition in which the voluptuous heart note of nobleJasmine Sambac is enlightened by delicate touches of Yellow Freesia, and rounded outby a lingering dry-down of Amber, White Musk and Cashmere Wood.

Discover these and other Beauty treats at Faces this Valentine’s Day!

Faces…your Beauty Vibes

Contacts

Joyce Amil

Euro RSCG Corporate Communications

joyce.amil@eurorscgme.com

Tel: +97 1 4 455 6000

-(BUSINESS WIRE)– STT Condigi, a leading provider of technology and services to the elderly home care and nursing home markets in the Nordic region, has announced today that it has entered into an agreement to be acquired by Tunstall Healthcare Group Limited, a leading telecare and telehealth provider based in the UK. Subject to the receipt of mandatory competition clearances, the transaction is expected to close at the end of February 2012. Kristoffer Axelsson, the STT Condigi CEO, will lead the combined Nordic business. Financial details of the transaction were not disclosed.

Headquartered in Malmo, Sweden STT Condigi has businesses in Sweden, Denmark, Finland and Norway as well as a growing export division. STT Condigi has been built from its suite of software services which are provided to local authorities and providers of care in the community which allow carer optimisation, mobile planning, activity reporting and mobile alarm handling. In addition it offers a range of independent living products as well as communications systems for nursing homes.

Torbjorn Olsson (Investment Manager), of the majority shareholder of STT Condigi, the 6th AP Fund said, “We are delighted to have negotiated the sale of STT Condigi with Tunstall Group. The two companies complement each other well. We have been pleased with both STT Condigi’s strong development and market position in the Nordics which we believe will be of great benefit to Tunstall. In addition, the management performance of STT Condigi has been excellent and we feel they will enhance and strengthen the combined Tunstall/STT Nordic business.”

“The decision by the board to join forces with Tunstall is a very positive move that is good for our business, employees and our customers,” said Kristoffer Axelsson, Chief Executive Officer of STT Condigi. “Tunstall has over 50 years experience of innovation and a true commitment to improving lives and enabling people to live more independently, which is perfectly aligned with STT Condigi’s mission. By joining with Tunstall, STT Condigi will have access to world class monitoring software and centres into which our applications will add extra services for our customers. In addition STT Condigi will have unprecedented access to Tunstall’s engineering, manufacturing and product portfolio as well as its global operating resources. This transaction will allow STT Condigi to rapidly accelerate the scope of our portfolio in both remote monitoring and call centre solutions thereby benefiting our entire customer base.”

Gil Baldwin, Chief Executive Officer of Tunstall Healthcare commented: “It is clear that STT Condigi will make a very positive addition to the Tunstall Group. Our visions are aligned and we complement each other in a number of areas. STT Condigi is a leading provider to our market and has a set of products and services that will enhance our offering and presence both within the Nordic countries and across the rest of the Tunstall Group. STT Condigi brings a strong track record of growth and innovation upon which we want to build. I am confident that together we will accelerate our delivery of leading edge products and services to our customers and all those who depend on us to live their lives as they wish – with independence and dignity. We welcome Kristoffer and his team to our Group”.

Castlegreen Partners served as financial adviser and Linklaters Advokatbyrå Aktiebolag served as legal adviser to Tunstall. Danske Bank acted as exclusive financial adviser and Mannheimer Swartling Advokatbyrå Aktiebolag acted as legal adviser to the Shareholders of STT Condigi in this transaction.

About Tunstall

Tunstall is a leading provider of telecare/telehealth solutions. Operating in more than 30 countries and employing over 1,800 people, Tunstall supports 2.5 million people around the world. Tunstall’s philosophy is simple – to protect, support and care for people – by providing healthcare technology and services that enable anyone requiring support and reassurance, such as older people or those with long term needs, to lead an independent life with dignity and reassurance.

Tunstall provides complete and fully-integrated telecare and telehealth solutions for home, assisted living and specialist care environments, hospital communication systems, associated support services, response centre software systems and monitoring services.

More information is available at www.tunstall.co.uk.

About STT Condigi

STT Condigi is a leading Nordic supplier of systems for safe, efficient care with a presence in the Nordics through wholly-owned subsidiaries and in Europe via a well developed distribution network. For more than 30 years, the company has developed its own products and complete solutions that streamline care work and provide care recipients with a higher level of safety.

STT Condigi has a broad range of skills and offers safety solutions for all types of residents, such as alarm systems for elderly residents in their own homes or complete internal systems for sheltered accommodation. We also offer ultra-modern equipment for alarm reception and advanced administrative systems for more efficient care. Our aim is both to increase safety for elderly and functionally-impaired people and to improve work conditions for care personnel, while also making care work more cost-effective.

STT Condigi has offices in Sweden (Malmö, Stockholm and Umeå), Denmark (Århus), Finland (Tampere) and in Spain (Madrid) and has a turnover of approximately 230 MSEK.

For more information, visit www.sttcondigi.com

Contacts

For Tunstall

Alison Rogan, UK Communications Director

+44 1977 661234

or

Press Contact: Context

01625 511966

tunstall@contextpr.co.uk

or

For STT Condigi

Kristoffer Axelsson, CEO

Phone: +46 40 6252544

kristoffer.axelsson@sttcondigi.com

-(BUSINESS WIRE)– NYSE Euronext (NYSE: NYX) announced today that in light of the decision by the European Commission to block the proposed merger agreement, both companies have agreed to a mutual termination of the business combination agreement originally signed by the Companies on February 15, 2011.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company’s exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext’s equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-third of the world’s equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world’s second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the Fortune 500. For more information, please visit: http://www.nyx.com.

Safe Harbour Statement

In connection with the proposed business combination transaction between NYSE Euronext and Deutsche Börse AG, Alpha Beta Netherlands Holding N.V. (“Holding”), a newly formed holding company, filed, and the U.S. Securities and Exchange Commission (“SEC”) declared effective on May 3, 2011, a Registration Statement on Form F-4 with the SEC that includes (1) a proxy statement of NYSE Euronext that also constitutes a prospectus for Holding, which was used in connection with NYSE Euronext special meeting of stockholders held on July 7, 2011 and (2) an offering prospectus used in connection with Holding’s offer to acquire Deutsche Börse AG shares held by U.S. holders. Holding has also filed an offer document with the German Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht) (“BaFin”), which was approved by the BaFin for publication pursuant to the German Takeover Act (Wertpapiererwerbs-und Übernahmegesetz), and was published on May 4, 2011. The acceptance period for the exchange offer expired on midnight, at the end of July 13, 2011 (Central European Daylight Savings Time), the additional acceptance period for the exchange offer expired on midnight, at the end of August 1, 2011 (Central European Daylight Savings Time). Pursuant to Section 39c of the German Takeover Act, shareholders of Deutsche Börse who had not yet accepted the exchange offer were still able to do so until midnight at the end of November 4, 2011 (Central European Time).

Investors and security holders are urged to read the definitive proxy statement/prospectus, the offering prospectus, the offer document, as amended, and published additional accompanying information in connection with the exchange offer regarding the proposed business combination transaction because they contain important information. You may obtain a free copy of the definitive proxy statement/prospectus, the offering prospectus and other related documents filed by NYSE Euronext and Holding with the SEC on the SEC’s website at www.sec.gov. The definitive proxy statement/prospectus and other documents relating thereto may also be obtained for free by accessing NYSE Euronext’s website at www.nyse.com. The offer document, as amended, and published additional accompanying information in connection with the exchange offer are available at Holding’s website at www.global-exchange-operator.com.

This document is neither an offer to purchase nor a solicitation of an offer to sell shares of Holding, Deutsche Börse AG or NYSE Euronext. The final terms and further provisions regarding the public offer are disclosed in the offer document that has been approved by the BaFin and in documents that have been filed with the SEC.

No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended, and applicable European regulations. The exchange offer and the exchange offer document, as amended, shall not constitute an issuance, publication or public advertising of an offer pursuant to laws and regulations of jurisdictions other than those of Germany, United Kingdom of Great Britain and Northern Ireland and the United States of America. The relevant final terms of the proposed business combination transaction will be disclosed in the information documents reviewed by the competent European market authorities.

Subject to certain exceptions, in particular with respect to qualified institutional investors (tekikaku kikan toshika) as defined in Article 2 para. 3 (i) of the Financial Instruments and Exchange Act of Japan (Law No. 25 of 1948, as amended), the exchange offer has not been made directly or indirectly in or into Japan, or by use of the mails or by any means or instrumentality of interstate or foreign commerce (including without limitation, facsimile transmission, telephone and the internet) or any facility of a national securities exchange of Japan. Accordingly, copies of this announcement or any accompanying documents may not be, directly or indirectly, mailed or otherwise distributed, forwarded or transmitted in, into or from Japan.

The shares of Holding have not been, and will not be, registered under the applicable securities laws of Japan. Accordingly, subject to certain exceptions, in particular with respect to qualified institutional investors (tekikaku kikan toshika) as defined in Article 2 para. 3 (i) of the Financial Instruments and Exchange Act of Japan (Law No. 25 of 1948, as amended), the shares of Holding may not be offered or sold within Japan, or to or for the account or benefit of any person in Japan.

Contacts

NYSE Euronext

Media Contacts

Robert Rendine, +1-212-656-2180

Rich Adamonis +1-212-656-2140

Caroline Nico + 33 1 49 27 10 74

or

Investor Relations

Stephen Davidson +1-212-656-2183

Phase III soft tissue sarcoma trial ongoing; randomized Phase II pancreatic cancer trial expected to report in February 2012
Deal provides Threshold with an upfront payment of € 19 million ($25 million), plus further potential milestones and royalties as well as an option to co-commercialize in the United States

-(BUSINESS WIRE)– Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that a global agreement was signed with Threshold Pharmaceuticals, Inc., South San Francisco, to co-develop and commercialize TH-302, Threshold’s small molecule hypoxia-targeted drug. TH-302 is currently being investigated in a global Phase III clinical trial in patients with soft tissue sarcoma, a randomized Phase II trial in patients with advanced pancreatic cancer from which top-line results are expected in February, as well as additional clinical studies in other solid tumors and hematological malignancies.

Under the terms of the agreement, Merck will receive co-development rights, exclusive global commercialization rights and will provide Threshold an option to co-commercialize the therapeutic in the United States. In exchange, Threshold will receive an upfront payment of € 19 million ($25 million) and could receive up to € 26.5 million ($35 million) in additional development milestones during 2012. Threshold is also eligible to receive a € 15 million ($20 million) milestone payment based on positive results from its randomized Phase II trial in pancreatic cancer.

In the United States, Threshold will have primary responsibility for development of TH-302 in the soft tissue sarcoma indication. Threshold and Merck KGaA will jointly develop TH-302 in all other cancer indications being pursued. Merck KGaA will pay 70% of worldwide development costs for TH-302.

Subject to FDA approval in the United States, Merck KGaA will initially be responsible for commercialization of TH-302 with Threshold receiving a tiered, double-digit royalty on sales. Under the royalty-bearing portion of the agreement, Threshold retains the option to co-promote TH-302 in the United States. Additionally, Threshold retains the option to co-commercialize TH-302 allowing the company to participate in up to 50% of the profits in the United States, based on certain revenue tiers. Outside of the United States, Merck KGaA will be solely responsible for the commercialization of TH-302 with Threshold receiving a tiered, double-digit royalty on sales in these territories.

“The addition of TH-302 to our pipeline provides an important opportunity in several different tumor types to expand our oncology development program,” said Susan Jane Herbert, Head of Global Business Development and Strategy, Merck Serono. “Given the fact that pancreatic cancer is a very difficult to treat indication, successful Phase II results could represent important upside for our company.”

“We are excited by the new resources that our partnership is going to bring to the development of TH-302, and the expertise in clinical development and commercialization that Merck will contribute to this program,” said Barry Selick, President and CEO of Threshold. “This collaboration provides Threshold a strong and committed partner with a shared vision for TH-302.”

TH-302 is a hypoxia-targeted drug that is thought to be activated under tumor hypoxic conditions, a hallmark for many cancer indications. Areas of low oxygen levels (hypoxia) within tissues are common in many solid tumors due to insufficient blood vessel growth. Similarly, the bone marrow of patients with hematological malignancies has also been shown, in some cases, to be extremely hypoxic.

TH-302 has been investigated in over 550 patients in Phase I/II clinical trials to date in a broad spectrum of tumor types, both as a monotherapy and in combination with chemotherapy treatments and other targeted cancer drugs.

Threshold has several ongoing clinical trials including, but not limited to: a controlled Phase II trial of TH-302 in combination with gemcitabine versus gemcitabine alone in patients with advanced pancreatic cancer and a Phase III study evaluating TH-302 in combination with doxorubicin versus doxorubicin alone in patients with soft tissue sarcoma.

TH-302 development in soft tissue sarcoma

A Phase III trial of TH-302 in patients with first-line advanced soft tissue sarcoma (STS) was initiated in September, 2011, based on results from a Phase I/II trial investigating its use in combination with the chemotherapeutic doxorubicin. This randomized, multi-center Phase III trial will investigate the use of TH-302 plus doxorubicin compared with doxorubicin alone. The primary efficacy endpoint is overall survival. The study is conducted under a Special Protocol Assessment with the U.S. Food and Drug Administration. It is being run in partnership with the Sarcoma Alliance for Research through Collaboration (SARC) and aims to enroll 450 patients with metastatic or locally advanced unresectable STS.

TH-302 development in pancreatic cancer

Results from a randomized, controlled, multi-center Phase II trial of TH-302 in patients with first-line pancreatic cancer are expected to be announced in February, 2012. This trial of 214 previously untreated patients with locally advanced unresectable or metastatic pancreatic adenocarcinoma started in June, 2010, and completed enrollment in June, 2011. Two different doses of TH-302 in combination with the chemotherapeutic gemcitabine were compared to gemcitabine alone, with progression free survival (PFS) as the primary endpoint.

Soft tissue sarcoma

STS refers to a heterogeneous and relatively rare group of tumors that develops in the soft, supporting tissues of the body. It can occur in any of the tissues that support, surround or protect the organs of the body, such as muscle, fat, nerves, tendons and ligaments or blood vessels. It can also develop in specific organs including, for example, the uterus, stomach, skin and small bowel. Occasionally it occurs in the head and neck. Adult STS is rare, with an estimated average incidence of 4 in 100,000 cases in Europe annually.1 In the United States, there were an estimated 10,980 new cases and 3,920 deaths from STS in 2011.2 STS tends to occur in people over the age of 30, although certain types of sarcoma can develop more commonly in children and teenagers.3 Current treatment options for STS include surgery, chemotherapy and radiotherapy, although response rates are generally low and side effects can be significant.

Pancreatic cancer

Pancreatic cancer is considered fairly rare, particularly in younger people. The most common symptoms are pain in the upper abdomen, weight loss, and jaundice. Current treatment options include surgery, radiotherapy and chemotherapy. It is estimated that approximately 279,000 cases of pancreatic cancer were diagnosed worldwide in 2008.4

References

1 Casali, PG et al on behalf of the ESMO Guidelines Working Group. Ann Oncol. 2010;20(4):iv132-iv136

2.National Cancer Institute. Snapshot of Sarcoma. 2011; http://www.cancer.gov/aboutnci/servingpeople/snapshots/sarcoma.pdf. Last accessed January 13, 2011.

3.Macmillan Cancer Support: http://www.macmillan.org.uk/Cancerinformation/Cancertypes/Softtissuesarcomas/Softtissuesarcomas.aspx. Last accessed January 16, 2011.

4. GLOBOCAN 2008. World estimated cancer incidence, all ages: both sexes. http://globocan.iarc.fr/summary_table_pop.asp?selection=221900&title=World&age_from=1&age_to=10&sex=0&type=0&PDF=1&window=1&sort=0&submit=%A0Execute%A0Last accessed February 1, 2012.

About Threshold Pharmaceuticals

Threshold is a biotechnology company focused on the discovery and development of drugs targeting tumor hypoxia, the low oxygen condition found in microenvironments of most solid tumors as well as the bone marrows of patients with some hematologic malignancies. For additional information, please visit the company’s website: www.thresholdpharm.com.

About Merck Serono

Merck Serono is the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, a global pharmaceutical and chemical company. Headquartered in Geneva, Switzerland, Merck Serono discovers, develops, manufactures and markets prescription medicines of both chemical and biological origin in specialist indications. In the United States and Canada, EMD Serono operates as a separately incorporated affiliate of Merck Serono.

Merck Serono has leading brands serving patients with cancer (Erbitux®, cetuximab), multiple sclerosis (Rebif®, interferon beta-1a), infertility (Gonal-f®, follitropin alfa), endocrine and metabolic disorders (Saizen® and Serostim®, somatropin), (Kuvan®, sapropterin dihydrochloride), (Egrifta®, tesamorelin), as well as cardiometabolic diseases (Glucophage®, metformin), (Concor®, bisoprolol), (Euthyrox®, levothyroxine). Not all products are available in all markets.

With an annual R&D expenditure of over € 1bn, Merck Serono is committed to growing its business in specialist-focused therapeutic areas including neurodegenerative diseases, oncology, fertility and endocrinology, as well as new areas potentially arising out of research and development in rheumatology.

About Merck

Merck is a global pharmaceutical and chemical company with total revenues of € 9.3 billion in 2010, a history that began in 1668, and a future shaped by more than 40,000 employees in 67 countries. Its success is characterized by innovations from entrepreneurial employees. Merck’s operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.

For more information, please visit www.merckserono.comor www.merckgroup.com

Contacts

Dr. Raphaela Farrenkopf

Phone +49 6151-72 2274

raphaela.farrenkopf@merckgroup.com